Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tumor angiogenesis].

F Bussolino1

  • 1Istituto per la Ricerca e la Cura del Cancro, Università, Torino. bussol@molinette.unito.it

Recenti Progressi in Medicina
|April 8, 1999
PubMed
Summary
This summary is machine-generated.

New vessel formation (angiogenesis) is vital for tumor growth and metastasis. Inhibiting angiogenesis can increase cancer cell death and induce dormancy without causing drug resistance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus clustering methodology to improve molecular stratification of non-small cell lung cancer.

Scientific reports·2023
Same author

TFEB inhibition induces melanoma shut-down by blocking the cell cycle and rewiring metabolism.

Cell death & disease·2023
Same author

Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity.

Journal of translational medicine·2016
Same author

Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy.

Journal of internal medicine·2012
Same author

Characterization of kaposis sarcoma-derived cell-cultures from an epidemic and a classic case.

International journal of oncology·2011
Same author

Symmetry breaking mechanism for epithelial cell polarization.

Physical review. E, Statistical, nonlinear, and soft matter physics·2009
Same journal

[Feasibility and impact of the collaboration between General Practitioners and Vaccination Centers in Herpes Zoster vaccination in Italy.]

Recenti progressi in medicina·2026
Same journal

[Lean and Value-Based Healthcare methods to support the chronic heart failure care model.]

Recenti progressi in medicina·2026
Same journal

[Drones and CBRN emergency management: operational perspectives and integrated training models for health response.]

Recenti progressi in medicina·2026
Same journal

[Non-profit clinical research in Italy: opportunities and unresolved challenges.]

Recenti progressi in medicina·2026
Same journal

[Therapeutic cannabis: between clinical potential, limitations of available evidence, and practical challenges in Italy.]

Recenti progressi in medicina·2026
Same journal

From Asimov's laws to Kasparov's laws: artificial intelligence, clinical work, and the design of hybrid intelligence.

Recenti progressi in medicina·2026
See all related articles

Area of Science:

  • Biomedical Science
  • Cell Biology
  • Oncology

Context:

  • Angiogenesis, the formation of new blood vessels, is essential for embryonic development.
  • Aberrant angiogenesis is a hallmark of cancer, fueling tumor growth and metastasis.
  • Tumor angiogenesis is initiated by cancer cell clones disrupting the balance of pro-angiogenic and anti-angiogenic factors.

Purpose:

  • To explore the role of angiogenesis in tumor progression.
  • To investigate the therapeutic potential of inhibiting angiogenesis in cancer treatment.

Summary:

  • Tumor growth and metastasis are critically dependent on angiogenesis.
  • Inhibiting angiogenesis can be achieved through natural or chemical compounds.
  • Targeting angiogenesis increases tumor apoptosis and has shown potential in inducing cancer dormancy in preclinical models.

Related Experiment Videos

Impact:

  • Inhibiting angiogenesis offers a promising strategy to combat cancer growth and spread.
  • This approach may overcome drug resistance associated with conventional cancer therapies.
  • The induction of cancer dormancy via anti-angiogenic strategies presents a novel therapeutic avenue.